期刊文献+

酒石酸布托啡诺用于全麻术后镇痛的临床观察 被引量:2

Clinic Observation of Butorphanol's Analgetic Effect on General Anaesthesia
下载PDF
导出
摘要 目的:评价布托啡诺用于全麻手术后进入麻醉复苏室的病人的可行性和安全性。方法:选择90例全麻病人随机分为布托啡诺组(A组=30)、杜冷丁组(B组=30)和不给予任何镇痛药物组(C组=30),A组给予酒石酸布托啡诺1~2mg静脉莫非氏滴管静注;B组给予杜冷丁50-100mg肌注。观察并记录A、B两组注药后10min、30min、1h、4h的疼痛视觉模拟评分(VAS值)、镇静评分(采用Ramsay评分)、生命体征的变化和不良反应的发生情况并与C组进行对照分析。结果:给予镇痛药的两组的镇痛镇静率均在86%以上,但是布托啡诺组的副反应如心慌、呼吸抑制较杜冷丁组少。布托啡诺组术后恶心、呕吐发生率低于不给药物组(P〈0.05),注药后1h布托啡诺组头晕和嗜睡的发生率明显高于杜冷丁组(P〈0.05)。结论:布托啡诺和杜冷丁用于麻醉复苏室患者均具有良好的术后镇痛效果,术后不良反应发生率低。 Objective: To evaluate the safety and feasibility of Butorphanol applied in post-operative patients with general anaesthesia. Methods: 90 cases of patients with general anaesthesia were selected and randomly divided into three groups. Group A were intravenously treated with Butorphanol, group B were intramuscularly treated with Pethidine, and group C as the control. These cases were observed and comparatively analyzed.Results: The rate of pain relief in both group A and B were over 86% .But there had less side effects in group A than those in group B, such as palpitation and breath suppress. And the rate of dizziness and somnolence was significantly higher in group A than those in group B. Conclusion: Butorphanol and Pethidine are safe and effective in resuscitation and have fewer side effects.
作者 刘战 袁永德
出处 《四川省卫生管理干部学院学报》 2009年第1期8-10,共3页 Journal of Sichuan Continuing Education College of Medical Sciences
关键词 PACU 布托啡诺 杜冷丁 PACU Butorphanol Pethidine
  • 相关文献

参考文献2

二级参考文献17

  • 1Zimmerman DM, Gidda JS, Cantrell BE, Shoepp DD,Johnson BG, Leander JD. Discovery of potent peripherally selective trans-3, 4-dimethyl-4-( 3-hydrox-yphenyl)piperidines opioid antagonist for the treatment of gastrointestinal motility disorders[J]. J Med Che
  • 2Zaki PA, Keith DE, Thomas JB, Carroll FI, Evans CJ. Agonist-, antagonist-, and inverse agonist-regulated trafficking of the δ-opioid receptor correlates with, but does not require, G protein activation[J]. J Pharmacol Exp Ther, 2001,298 : 1015-1020.
  • 3Thomas JB, Atkinson RN, Rothman RB, Fix SE,Mscarella SW, Vinson NA, Xu H, Dersch CM, Lu Y, Cantrell BE, Zimmerman DM, Carroll FI. Identification of the first trans- ( 3R, 4R) -dimethyl - 4- (3-hydroxyphenyl)piperidines derivative to possess highly potent
  • 4Thomas JB, Atkinson RN, Vinson NA, Catanzro JL,Perretta CL, Fix SE, Mscarella SW, Rothman RB,Xu H, Dersch CM, Cantrell BE, Zimmerman DM,Carroll FI. Identification of (3R)-7- hydroxy-N-1-{[( 3R, 4R )-4-( 3-hydro-xyphenyl )-3, 4-imethyl-1piperidinyl ] methy
  • 5Grundt P, Jales AR, Traynor JR, Lewis JW, Husbands SM. 14-Amino, 14-Alkylmino, and 14-Acylamino Analogs of Oxymorphindole. Differetial Effects on Opioid Recetor Binding and Functional Profiles[J].J Med Chem, 2003,46:1563-1566.
  • 6Mitch CH, Mendelsohn LG, Shaw WN, Wong DT,Cantrell BE, Johnson BG, Reel JK, Snoddy JD, Takemori E, Zimmerman DM. 3, 4,-Dimethyl-4-(3-hydroxyphenyl) piperidines: Opioid antagonists with potent anorectant activity[J]. J Med Chem, 1993, 36:2842-2850.
  • 7Thomas JB, Mascarella SW, Rothman RB, Partill JS,Xu H, McCullough KB, Dersch CM, Carroll FI. Investigation of the N-substituent conformation governing potency and μ receptor subtype- selectivity in (+)-(3R, 4R )-dimethyl-4- ( 3-hydroxyphenyl ) piperidine
  • 8Thomas JB, Fall MJ, Cooper JB, Rothman RB,Mscarella SW, Xu H, Partilla JS, Dersch CM, McCullough KB, Cantrell BE, Zimmerman DM, Carroll FI. Identification of an opioid κ receptor subtype-selective N-substituent for ( + )- (3R, 4R)-dimethyl-4-(3-hydroxyph
  • 9Thomas JB, Zheng XL, Mscarella SW, Rothman RB,Dersch CM, Partilla JS, Flippen-Anderso JL, George CF, Cantrell BE, Zimmerman DM, Carroll FI. Nsubstituted 9β-methyl-5-(3-hydroxylphenyl) morphans are opioid receptor pure antagonists[J]. J Med Chem,1998,41 :
  • 10Thomas JB, Mscarella SW, Burgess JP, Xu H, Mc-Cullough KB, Rothman RB, Flippen-Anderso JL,George CF, Cantrell BE, Zimmerman DM, Carroll FI. N-substituted octahydro-4α-(3-hydroxyphenyl) -10α-methyl-benzo[g]isoquinolines are opioid receptor pure antagonis

共引文献4

同被引文献11

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部